SCA
CVS icon

Sippican Capital Advisors’s CVS Health CVS Stock Holding History

Sippican Capital Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-8,970
Closed -$667K – 103
2023
Q1 		$667K Sell
8,970
-7,635
-46% -$640K 0.64% 62
2022
Q4 		$1.55M Sell
16,605
-192
-1% -$18.5K 1.48% 20
2022
Q3 		$1.6M Hold
16,797
– – 1.67% 17
2022
Q2 		$1.56M Hold
16,797
– – 1.54% 21
2022
Q1 		$1.7M Sell
16,797
-361
-2% -$37.9K 1.41% 23
2021
Q4 		$1.77M Sell
17,158
-31
-0.2% -$2.87K 1.5% 23
2021
Q3 		$1.46M Sell
17,189
-25
-0.1% -$2.09K 1.26% 31
2021
Q2 		$1.44M Hold
17,214
– – 1.25% 33
2021
Q1 		$1.29M Hold
17,214
– – 1.2% 34
2020
Q4 		$1.18M Sell
17,214
-1,675
-9% -$109K 1.28% 31
2020
Q3 		$1.1M Buy
18,889
+1,876
+11% +$117K 1.37% 26
2020
Q2 		$1.1M Buy
17,013
+236
+1% +$14.9K 1.49% 26
2020
Q1 		$995K Buy
16,777
+2,586
+18% +$173K 1.62% 24
2019
Q4 		$1.05M Buy
14,191
+1,848
+15% +$130K 1.17% 33
2019
Q3 		$778K Buy
12,343
+4,738
+62% +$281K 0.94% 42
2019
Q2 		$414K Buy
+7,605
New +$410K 0.49% 71
2017
Q4 		– Sell
-4,635
Closed -$377K – 102
2017
Q3 		$377K Sell
4,635
-120
-3% -$9.49K 0.39% 76
2017
Q2 		$383K Sell
4,755
-415
-8% -$32.8K 0.42% 71
2017
Q1 		$406K Sell
5,170
-1,736
-25% -$139K 0.43% 71
2016
Q4 		$545K Sell
6,906
-652
-9% -$52.8K 0.57% 60
2016
Q3 		$673K Buy
7,558
+2,870
+61% +$271K 0.77% 50
2016
Q2 		$449K Buy
4,688
+1,188
+34% +$118K 0.53% 62
2016
Q1 		$363K Buy
3,500
+853
+32% +$82.9K 0.46% 70
2015
Q4 		$259K Buy
+2,647
New +$259K 0.33% 81

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Sippican Capital Advisors's CVS Position: Q2 2023 in Review

Sippican Capital Advisors sold out of CVS Health (CVS) in Q2 2023, closing a stake of 8,970 shares — an estimated $667K sold.

Sippican Capital Advisors first reported a position in CVS in Q4 2015 and held it in 24 quarters. The position peaked at $1.77M in Q4 2021. 2,203 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

  • Sippican Capital Advisors reported no remaining CVS Health position as of Q2 2023 after selling out during the quarter.
  • Sippican Capital Advisors sold 8,970 CVS Health shares in Q2 2023, an estimated $667K.
  • Sippican Capital Advisors first reported a position in CVS Health in Q4 2015 and held it in 24 quarters.
  • Sippican Capital Advisors's CVS Health position peaked at $1.77M in Q4 2021.
  • 2,203 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on Sippican Capital Advisors's 13F filing for Q2 2023, filed 15 Aug 2023.